Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

2.36
Delayed Data
As of 11:26am ET
 +0.015 / +0.64%
Today’s Change
0.63
Today|||52-Week Range
4.24
-15.59%
Year-to-Date
No recent news for Aveo Pharmaceuticals Inc.

Today’s Trading

Previous close2.34
Today’s open2.35
Day’s range2.33 - 2.41
Volume707,633
Average volume (3 months)1,783,361
Market cap$263.9M
Data as of 11:26am ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)-56.41%
Earnings growth (this year)+56.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+201.35%
P/E ratioNM
Price/Sales39.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ACIUAC Immune SA+0.13+1.27%
SVASinovac Biotech Ltd-0.10-1.31%
CARACara Therapeutics In...+3.51+30.26%
DEPODepomed Inc+0.14+2.09%
Data as of 11:41am ET, 05/23/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$7.6M
Annual profit (last year)-$65.0M
Net profit margin-857.96%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael P. Bailey
Chief Financial Officer
Matthew D. Dallas
Corporate headquarters
Cambridge, Massachusetts

Forecasts